Below is a post from one markd .. posted to a
nutrition list.
He SPECIFICALLY tells people NOT to attempt to use the
method of hemodilution / bloodletting to prevent
vision loss ..
He has been repeatedly asked to supply credentials or
'cites' / medical citations to bolster his .. advice ..
He cannot and/or .. refuses ..
But he is DETERMINED to attempt to steer diabetics AWAY from
studies / research which SPECIFICALLY speak to IMPROVEMENT
of eyes in over 43% of diabetics ..
Quoted message said:Subject: Re: Prevention of vision loss / diabetes From: markd@toad-
net.com Date: 6/11/2004 3:17 PM Mountain Daylight Time Message-
id: <[email hidden]>
Quoted message said:Tom, not only should diabetics not do bloodletting, for
some it would be very bad as they require iron
supplementation to fight iron anemia.
biospace.comnews story.cfmOpen ↗
l=1
These data suggest the key to minimizing vision loss is
earlier detection through increased screenings and
treatments that inhibit progression of diabetic macular
edema toward the center of the macula.
------------------------------------------------------------
--------------
---------------------------
Graefes Arch Clin Exp Ophthalmol. 2001 Dec;239(12):909-14.
Related Articles, Links
Effect of isovolemic hemodilution in central retinal vein
occlusion.
Glacet-Bernard A, Zourdani A, Milhoub M, Maraqua N, Coscas
G, Soubrane G.
University Eye Clinic of Creteil, Intercommunal and Henri
Mondor (Assistance Publique des Hjpitaux de Paris)
Hospitals, University of Paris XII, France.
[email hidden]
BACKGROUND: Hemorheologic abnormalities have recently been
shown to play a role in the pathogenesis of retinal vein
occlusion (RVO), and several studies have demonstrated the
efficacy of isovolemic hemodilution in these eyes. This
study was designed to investigate further the effects of
hemodilution, with regard to the duration of symptoms before
the treatment. METHODS: In a prospective study, 142 eyes
with central or hemicentral RVO were treated by isovolemic
hemodilution. The target hematocrit value was 35%. Mean
duration of follow-up was 10 months. A subgroup of 50
patients treated within 2 weeks of the onset of symptoms was
compared first with patients treated later by hemodilution,
and then retrospectively with controls with central RVO and
without hemodilution. RESULTS: Hemodilution therapy resulted
in a decrease in hematocrit level from 42% to 32% on
average, with no major side effect. After treatment, a
significant decrease was observed in hemorheologic
parameters (fibrinogen, erythrocyte aggregation), except in
plasma viscosity. Retinal circulation times were
significantly shortened. Visual acuity (VA) improvement
immediately after treatment (in 43% of eyes) was correlated
with better final visual outcome (P<0.05). At the end of follow-
up, VA was better in patients treated within the first 2
weeks than in those treated later and in controls (41% had
VA of 20/40 or more in the early-treatment group versus 23%
in the late-treatment group, P<0.01). Final retinal ischemia
was also greater in the late-treatment group and in
controls. Hemodilution in 12 patients with long-standing RVO
and macular edema was ineffective. CONCLUSION: Our study is
consistent with previous investigations that confirmed the
efficacy of isovolemic hemodilution in RVO on hemorheologic
parameters, retinal circulation times and final VA. It also
underlined strongly the benefit of early treatment within
the first 2 weeks of the RVO. Further studies are required
to confirm these results.
PMID: 11820695 [PubMed - indexed for MEDLINE]
------------------------------------------------------------
--------------
------
Who loves ya. Tom
Jesus Was A Vegetarian! jesuswasavegetarian.7h.comjesuswasavegetarian.7h.comOpen ↗
Man Is A Herbivore!
pages.ivillage.commanisaherbivoreOpen ↗ DEAD
PEOPLE WALKING
pages.ivillage.comdeadpeoplewalkingOpen ↗